MedTrace Logo

TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

NCT05729711 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 416

Last updated 2026-03-27

No results posted yet for this study

Summary

The purpose of the investigation is to confirm the followings under the post-marketing actual long-term use of Tezspire.

1. Development of related AEs
2. Contributing factors possibly having an impact on the safety and effectiveness
3. Development of unexpected related AEs

Conditions

  • Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)

Sponsors & Collaborators

Principal Investigators

  • Toshimitsu Tokimoto · AstraZeneca KK

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-04
Primary Completion
2029-11-16
Completion
2029-11-16

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05729711 on ClinicalTrials.gov